Status:
NOT_YET_RECRUITING
Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Cancer
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
Eligibility:
All Genders
18+ years
Brief Summary
Immunotherapy is a therapeutic strategy aimed at inducing the immune system to identify and combat cancer cells and, alongside the evident clinical success observed in many patients, a specific toxici...
Detailed Description
Immunotherapy is a therapeutic strategy aimed at inducing the immune system to identify and combat cancer cells. The rationale behind immunotherapy lies in the context of an altered homeostasis betwee...
Eligibility Criteria
Inclusion
- Any male or female patient (≥18 years old) with diagnosis of solid or hematologic tumor scheduled to begin immunotherapy treatment (prospective)
- Any male or female patient (≥18 years old) with diagnosis of solid or hematologic tumor already in treatment with immunotherapy with development of irAEs (retro/prospective)
- Any male or female patient (≥18 years old) with diagnosis of solid or hematologic neoplasm previously treated with immunotherapy and history of irAEs (retrospective)
- Patients able to understand and sing an informed consent form (prospective group)
Exclusion
- Patients \< 18 years of age
- Patients with uncertain diagnosis of solid or hematologic tumor
- Patients not eligible for any clinical reason for immunotherapy
- Patients unable to understand or sign an informed consent form
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2045
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07198958
Start Date
October 1 2025
End Date
September 1 2045
Last Update
September 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.